ARCHIVES

Joint NCI/FDA Program approved; ‘May Solve Our Differences’

This article is from The Cancer Letter archive.

Vol. 15 No. 48 | December 15, 1989

Download PDF Visit The Full Archive

Related Articles

Approval Granted For New Formulation of Lupron Depot

July 29, 2011

The President’s Cancer Panel publishes its annual report

May 6, 2011

In Brief: Oldham to Leave NCI, Herberman Acting Head Of BRMP; Lansky Appointed Director Of ICC

November 11, 1983

John Montgomery Named to Replace Harold Amos On Cancer Panel

April 8, 1983

Sarcoma Survivors At Risk Of Blood Clots, Study Finds

May 25, 2007

Clinical Oncology Program Has Top Priority Fink Says

February 9, 1979